AU5270499A - Formulations having probiotically active microorganisms - Google Patents
Formulations having probiotically active microorganismsInfo
- Publication number
- AU5270499A AU5270499A AU52704/99A AU5270499A AU5270499A AU 5270499 A AU5270499 A AU 5270499A AU 52704/99 A AU52704/99 A AU 52704/99A AU 5270499 A AU5270499 A AU 5270499A AU 5270499 A AU5270499 A AU 5270499A
- Authority
- AU
- Australia
- Prior art keywords
- formulations
- active microorganisms
- probiotically active
- probiotically
- microorganisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0136098A AT407008B (en) | 1998-08-06 | 1998-08-06 | FORMULATIONS WITH PROBIOTALLY EFFECTIVE MICROORGANISMS |
AT1360/98 | 1998-08-06 | ||
PCT/AT1999/000192 WO2000007571A2 (en) | 1998-08-06 | 1999-07-29 | Formulations having probiotically active microorganisms |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5270499A true AU5270499A (en) | 2000-02-28 |
Family
ID=3512210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52704/99A Abandoned AU5270499A (en) | 1998-08-06 | 1999-07-29 | Formulations having probiotically active microorganisms |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1102580A2 (en) |
AT (1) | AT407008B (en) |
AU (1) | AU5270499A (en) |
WO (1) | WO2000007571A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767203B2 (en) * | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
AU2001272369A1 (en) * | 2000-07-17 | 2002-01-30 | Chr. Hansen A/S | Methods and formultations with probiotic microorganisms and medicaments |
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
EP1287745A1 (en) | 2001-08-24 | 2003-03-05 | The Procter & Gamble Company | Chewable compositions with probiotic agents |
DE102006054260A1 (en) * | 2006-02-28 | 2007-09-27 | Lohmann Animal Health Gmbh & Co. Kg | Water stabilizing composition, process for its preparation and its use |
RU2560425C2 (en) * | 2008-08-28 | 2015-08-20 | Кр. Хансен А/С | Stabiliser of colour in bacterial composition |
EP2398890B1 (en) * | 2009-02-23 | 2015-07-29 | Chr. Hansen A/S | Method for making lactid acid bacteria composition |
FR2963239B1 (en) * | 2010-08-02 | 2013-03-08 | Vetalis | SOLAR EFFERVESCENT GALENIC FORMS FOR ANIMALS |
EP2600877A4 (en) | 2010-08-04 | 2014-05-07 | Borody Thomas J | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
TR201007613A2 (en) * | 2010-09-16 | 2012-04-24 | Yed�Tepe �N�Vers�Tes� | Lyophilized biopesticide effervescent granules and production method |
JP2014507481A (en) | 2011-03-09 | 2014-03-27 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | Compositions and methods for colonic microbiota transplantation |
WO2013176774A1 (en) | 2012-05-25 | 2013-11-28 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
CN103550401B (en) * | 2013-11-19 | 2016-06-22 | 浙江美保龙生物技术有限公司 | A kind of preparation method of composite microbial ecological agent effervescent tablet |
AU2015245942A1 (en) * | 2014-04-09 | 2016-10-20 | Kambouris Shares Pty Ltd | Methods and compositions for delivering a probiotic |
KR102561989B1 (en) | 2015-05-14 | 2023-07-31 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
AU2016268158B2 (en) | 2015-05-22 | 2022-03-17 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
US11026978B2 (en) | 2016-10-11 | 2021-06-08 | Finch Therapeutics Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
CN110831606A (en) | 2017-04-05 | 2020-02-21 | 克雷斯顿沃控股公司 | Compositions and methods for treating Parkinson's Disease (PD) and related disorders |
US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
EP3630190B1 (en) | 2017-05-26 | 2024-02-21 | Finch Therapeutics Holdings LLC | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
US11865145B2 (en) | 2017-08-07 | 2024-01-09 | Finch Therapeutics Holdings Llc | Compositions and methods for maintaining and restoring a healthy gut barrier |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
US11911419B2 (en) | 2018-09-27 | 2024-02-27 | Finch Therapeutics Holdings Llc | Compositions and methods for treating epilepsy and related disorders |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1061894A (en) * | 1963-03-01 | 1967-03-15 | Lucien Nouvel | Therapeutically active bacterial preparations |
FR3626M (en) * | 1963-11-13 | 1965-10-18 | Lucien Nouvel | Medicine for intestinal complaints. |
FI840816A0 (en) * | 1984-03-01 | 1984-03-01 | Farmos Oy | BAKTERIEPREPARAT |
EP0203586A3 (en) * | 1985-05-29 | 1988-03-09 | Pioneer Hi-Bred International | A composition for treating gastrointestinal disease in animals |
GB8908361D0 (en) * | 1989-04-13 | 1989-06-01 | Beecham Group Plc | Composition |
DE4033996A1 (en) * | 1990-10-25 | 1992-04-30 | Karl Heinz Hoelzel | Capsules for normalising intestinal flora - contg. freeze-dried Lactobacillus and Bifidobacterium cultures |
US5340577A (en) * | 1992-07-29 | 1994-08-23 | The United States Of America, As Represented By The Secretary Of Agriculture | Probiotic for control of salmonella |
CA2156859A1 (en) * | 1993-02-24 | 1994-09-01 | Sherwood L. Gorbach | Method of enhancing immune response to oral vaccines |
US5785990A (en) * | 1995-07-10 | 1998-07-28 | Merrick's, Inc. | Feed fortifier and enhancer for preruminant calves and method of using same |
AT405235B (en) * | 1995-11-02 | 1999-06-25 | Helmut Dr Viernstein | PROBIOTALLY EFFECTIVE FORMULATION |
FR2770778B1 (en) * | 1997-11-12 | 2000-05-26 | Investigations Therapeutiques | COMPOSITION FOR THE TREATMENT OF ACUTE GASTROENTERITIS, MANUFACTURING METHOD THEREOF AND TREATMENT SOLUTION OBTAINED FROM THIS COMPOSITION |
-
1998
- 1998-08-06 AT AT0136098A patent/AT407008B/en not_active IP Right Cessation
-
1999
- 1999-07-29 WO PCT/AT1999/000192 patent/WO2000007571A2/en not_active Application Discontinuation
- 1999-07-29 AU AU52704/99A patent/AU5270499A/en not_active Abandoned
- 1999-07-29 EP EP99938048A patent/EP1102580A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000007571A2 (en) | 2000-02-17 |
EP1102580A2 (en) | 2001-05-30 |
AT407008B (en) | 2000-11-27 |
WO2000007571A3 (en) | 2000-05-11 |
ATA136098A (en) | 2000-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5270499A (en) | Formulations having probiotically active microorganisms | |
AUPP427398A0 (en) | Improved disinfection | |
AU1916599A (en) | Sachet formulations | |
AU2215495A (en) | Enzymatic antimicrobial compositions | |
AU1433299A (en) | Disinfecting agent | |
AU1878601A (en) | Enzyme | |
AU6604598A (en) | Farm implement | |
AU1412400A (en) | Hydrophilic member | |
AU6763198A (en) | Stabilized solid bacteria compositions | |
AU1969800A (en) | Combination of active agents | |
AU5965399A (en) | Pharmaceutically active composition | |
AU1560200A (en) | Disinfecting agents | |
AU2656799A (en) | Metal-thiols as imminomodulating agents | |
AU7432698A (en) | Disinfectant composition | |
AU4064699A (en) | Insecticide | |
AUPP715098A0 (en) | Cultivator point assembly | |
AU3740499A (en) | Agricultural adjuvant | |
AU2713300A (en) | Stable aqueous enzyme compositions | |
AU3538699A (en) | Novel physiologically active substances | |
AU4031299A (en) | Perfumes comprising 4-isobutylcyclohexanols | |
AU4384497A (en) | Insect-repellent formulations | |
AU1649700A (en) | Novel formulation | |
AU2647099A (en) | Active splitter | |
AU2648999A (en) | Absorbent | |
AU4521599A (en) | Germicidal composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |